Clinical Trial Update: Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating naltrexone as an adjunctive treatment in patients with alcohol use disorder and cocaine use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Cocaine Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Alcohol-Related Disorders, Cocaine-Related Disorders | Phase 2 | Status: COMPLETED